Literature DB >> 10514340

Solubilization of fluasterone.

L Zhao1, P Li, S H Yalkowsky.   

Abstract

Solubilization of nonpolar drugs constitutes one of the most important tasks in parenteral formulations design. This study investigates and assesses the solubility enhancement of Fluasterone by various techniques including cosolvency, micellization, and complexation. Of the solubilizing agents used, the modified beta-cyclodextrins were found to be the most effective. The solubility of Fluasterone is 1.55 x 10(-4) mM, 3.13 mM, and 4.04 mM in water, 20% sulfobutyl ether-beta-cyclodextrin (SBEbetaCD), and 20% hydroxypropyl-beta-cyclodextrin (HPbetaCD), respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514340     DOI: 10.1021/js9901413

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

Review 1.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

2.  Various solvent systems for solubility enhancement of enrofloxacin.

Authors:  Neelam Seedher; Pooja Agarwal
Journal:  Indian J Pharm Sci       Date:  2009-01       Impact factor: 0.975

3.  Solubilization of cyclosporin A.

Authors:  Y Ran; L Zhao; Q Xu; S H Yalkowsky
Journal:  AAPS PharmSciTech       Date:  2001-01-18       Impact factor: 3.246

4.  Solubility enhancement of Cox-2 inhibitors using various solvent systems.

Authors:  N Seedher; S Bhatia
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.